All Episodes
Featured
FDA Warns of Vision Loss From All GLP1 Drugs
•35:24

FDA Warns of Vision Loss From All GLP1 Drugs

In this episode

On November 9, 2026 the FDA announced that Ozempic, Wegovy, Mounjaro & Zepbound must have warning labels that these GLP1 drugs can cause sudden, severe, irreversible vision loss or blindness from a condition called NAION. NAION is a disease where the optic nerve suddenly loses its blood supply - essentially a stroke of the optic nerve. Watch this interview with the world's leading expert on this condition, Harvard neuro-ophthalmologist, Joseph Rizzo, M.D. Dr. Rizzo described the first patients with this condition in a medical journal publication in July 2024. DoctorPodcasts interviewed him at that time and now has an update with Dr. Rizzo in view of the new FDA warning.